|
|
| Research article summary (published 30 Aug 2009): |
The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
Full Abstract
BACKGROUND: Low antithrombin levels may compromise the anticoagulant effect of heparin and heparin-related compounds, such as fondaparinux. METHODS: We compared the anticoagulant effect of 10 concentrations of fondaparinux added to plasma samples with normal range (n = 25, antithrombin 95.4% +/- 9.2%) and low antithrombin (n = 22, antithrombin 45.5% +/- 13.2%) levels, using the Heptest coagulation assay. RESULTS: Heptest clotting time was shorter at any given fondaparinux concentration in the antithrombin-deficient samples, indicating less anticoagulant effect than in the group with normal antithrombin levels. At a high fondaparinux concentration, a saturation effect is observed with no further increase in Heptest clotting time. Addition of antithrombin concentrates results in a shift of the dose-response curve. When antithrombin concentrate was added, Heptest clotting time increased up to a fondaparinux concentration of 10 microg/mL. CONCLUSIONS: In the conventional prophylactic and therapeutic dose range, not only treatment with antithrombin concentrates but also an increase in fondaparinux dose normalizes the anticoagulant effect. A saturation effect is observed at high fondaparinux concentrations. Higher levels of antithrombin lead to an exaggerated effect of fondaparinux on Heptest.
Author information
Author/s: Dempfle, Carl-Erik (CE); Eichner, Julia (J); Suvajac, Nenad (N); Ahmad-Nejad, Parviz (P); Neumaier, Michael (M); Borggrefe, Martin (M);
Affiliation: I. Department of Medicine, University Medical Centre Mannheim, Mannheim, Germany. carl-erik.dempfle(-atsign-)umm.de
Journal and publication information
Publication Type: Journal Article
Journal: Anesthesia and analgesia (Anesth Analg), published in United States. (Language: eng)
Reference: 2009-Sep; vol 109 (issue 3) : pp 712-6
Dates: Created 2009/08/19; Completed 2009/09/09;
PMID: 19690236, status: MEDLINE (last retrieval date: 9/9/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site.
30 Dec 2002 - Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases.
2 Mar 2008 - Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
15 Feb 2005 - Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
29 Jun 1999 - Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.
21 Dec 2008 - In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation.
30 Aug 2002 - Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide.
4 Mar 2003 - [Immunostimulating and anticoagulating activity of fucoidan from brown algae Fucus evanescens of Okhotskoe sea]
30 Dec 2002 - Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.
30 Mar 2007 - Anticoagulant and antithrombin activities of oversulfated fucans.
20 May 1992
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.